Telo Genomics Corp. (TSXV: TELO) Stock Analysis & Fundamentals | ScreenerHero

Create free account

TELOTelo Genomics Corp.

TSXV · CA · Healthcare · Diagnostics & Research · telodx.com

0.0450CAD0.00%Mkt Cap: 3.29M $P/E: —2d ago

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily …

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap3.29M $

Enterprise Value3.54M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-1.98M $

Revenue/Share—

Last Price0.0450 CAD

Fiscal Year EndJun 2025

MR QuarterMar 2026

Employees—

CountryCA

SectorHealthcare

IndustryDiagnostics & Research

ISINCA87975M2085

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-2.59

EV/Revenue—

P/S—

P/B-4.50

EPS (TTM)-0.03

EPS (Forward)—

52W Range

0.035011% of range0.1250

52W High0.1250 CAD

52W Low0.0350 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-527.93%

ROA-298.34%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.70M $

CapEx (TTM)2.37K $

FCF Margin—

FCF Yield-8.97%

Net Debt247.31K $

Net Debt/EBITDA-0.18

Balance Sheet

Debt/Equity—

Current Ratio0.09

Quick Ratio0.07

Book Value/Sh-0.0100 CAD

Cash/Share0.0100 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay DateNov 22, 2019

Splits

Last Split1:5

Split DateNov 22, 2019

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.100.43M

Float74.45M

Insiders2.98%

Institutions0.40%

Short Interest

Short Ratio0.3d

Short % Out.0.01%

Shares Short5.82K

Short (prev mo.)2.27K

Technical

SMA 500.0540 (-16.7%)

SMA 2000.0533 (-15.6%)

Beta—

S&P 52W Chg20.25%

Avg Vol (30d)60.53K

Avg Vol (10d)6.72K

Technical Indicators

RSI (14)42.9

MACD-0.0034

MACD Signal-0.0033

MACD Hist.-0.0001

BB Upper0.0649 CAD

BB Middle0.0493 CAD

BB Lower0.0336 CAD

BB Width63.56%

ATR (14)0.0034 CAD

Vol Ratio (20d)0.00x